Clinical trials
Withdrawn Glioma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 4 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 58 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 6 |
| Fuda Cancer Hospital, Guangzhou | 3 |
| Jonsson Comprehensive Cancer Center | 2 |
| NYU Langone Health | 2 |
| National Cancer Institute (NCI) | 2 |
| University of Michigan Rogel Cancer Center | 2 |
| University of Texas Southwestern Medical Center | 2 |
| Washington University School of Medicine | 2 |
| Alberta Health services | 1 |
| Annick Desjardins | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 58 |
| Glioblastoma | 29 |
| Astrocytoma | 17 |
| Brain Neoplasms | 15 |
| Ependymoma | 10 |
| Oligodendroglioma | 10 |
| Gliosarcoma | 7 |
| Medulloblastoma | 6 |
| Neuroectodermal Tumors, Primitive | 6 |
| Central Nervous System Neoplasms | 4 |
Trials
Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.